N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance
2024 · Oncogene · 25 citations
https://doi.org/10.1038/s41388-024-03092-3
M
Mingjian Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
198
Citations
9
h-index
8
i10-index
Mingjian Ma is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Immunotherapy and Biomarkers & RNA modifications and cancer. The author has an h-index of 9, co-authored 18 publications.
Papers by this author
worksEctopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
2024 · Cancer Immunology Immunotherapy · 15 citations
https://doi.org/10.1007/s00262-024-03648-y
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer
2024 · Cancer Immunology Immunotherapy · 11 citations
https://doi.org/10.1007/s00262-024-03786-3
Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma
2023 · Current Oncology · 6 citations
https://doi.org/10.3390/curroncol30020126
Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinoma
2025 · Cancer Immunology Immunotherapy · 0 citations
https://doi.org/10.1007/s00262-025-04205-x
Positive Feedback Loop of Histone Lactylation‐Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance
2025 · Advanced Science · 0 citations
https://doi.org/10.1002/advs.202510483
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat